
浏览全部资源
扫码关注微信
纸质出版日期:2014
移动端阅览
祝继英, 秦佰焰, 王明贤, 等. 疏肝健脾方治疗糖尿病前期46例[J]. 中国实验方剂学杂志, 2014,20(14):188-192.
ZHU Ji-ying, QIN Bai-yan, WANG Ming-xian, et al. Shugan Jianpi Decoction Treatment Early-stage Diabetes with 46 Cases[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(14): 188-192.
祝继英, 秦佰焰, 王明贤, 等. 疏肝健脾方治疗糖尿病前期46例[J]. 中国实验方剂学杂志, 2014,20(14):188-192. DOI: 10.13422/j.cnki.syfjx.2014140188.
ZHU Ji-ying, QIN Bai-yan, WANG Ming-xian, et al. Shugan Jianpi Decoction Treatment Early-stage Diabetes with 46 Cases[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(14): 188-192. DOI: 10.13422/j.cnki.syfjx.2014140188.
目的: 观察疏肝健脾方对糖尿病前期患者糖代谢、脂代谢的调节作用及对炎性因子的影响。 方法: 91例糖尿病前期患者随机按就诊顺序分为对照组45例和观察组46例。对照组服用吡格列酮二甲双胍片,1片/次,2次/d。观察组服用疏肝健脾方,1剂/d。两组疗程均为12周。测量治疗后体重、腰围;检测治疗前后血脂水平,包括甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)及低密度脂蛋白胆固醇(LDL-C);检测治疗前后空腹血糖(FBG)、空腹胰岛素(FINS)、餐后2 h血糖(2 hPG)及糖化血红蛋白(HbAlc),计算体重指数(BMI)、胰岛素抵抗指数(HOMA-IR)、胰岛β细胞分泌功能指数(HOMA-IS)和胰岛素敏感指数(ISI);检测治疗前后血清脂联素(APN)、白细胞介素(IL-6)和超敏C-反应蛋白(hs-CRP)水平。 结果: 治疗后两组腰围和BMI均较治疗前下降,组间比较差异无统计学意义,治疗后两组体重均呈下降趋势;观察组FBG,2 hPG,HbA1c及FINS水平低于对照组(P<0.05或P<0.01);观察组HOMA-IR低于对照组(P<0.01),HOMA-IS和ISI高于对照组(P<0.01);观察组TC,TG,LDL-C和HDL-C单项指标转为正常例数多于对照组(P<0.01);观察组血清APN高于对照组(P<0.01),观察组IL-6和hs-CRP水平低于对照组(P<0.01)。 结论: 疏肝健脾方能调节糖尿病前期患者的糖代谢、脂代谢,延缓或逆转其进展为糖尿病的速度,其作用机制可能与调节APN,IL-6及hs-CRP等因子有关。
Objective: Observe regulating effect of Shugan Jianpi decoction to patients' glucose metabolism and lipid metabolism in treating early-stage diabetes and influence to inflammatory factor. Method: Ninety-one patients with early-stage diabetes were randomly divided into control group (45 cases) and observation group (46 cases)according to registration order.Patients in control group received pioglitazone hydrochloride and metformin hydrochloride tablets
1 tablet/time
2 times/day
taken orally.Patients in observation group received Shugan Jianpi decoction
1 dose/day.Course of treatment in two groups were both 12 weeks.After treatment
patients' weight and waist were measured.and levels of blood lipid was detected which including triglyceride(TG)
total cholesterol(TC)
high-density lipoprotein(HDL-C) and low density lipoprotein(LDL-C).Before and after treatment
fasting blood-glucose(FBG)
fasting insulin(FINS)
2 hours postprandial blood glucose(2 hPG) and glycosylated hemoglobin(HbAlc) were detected.body mass index(BMI)
homeostasis model assessment-insulin resistance index(HOMA-IR) of insulin
homeostasis model assessment-insulin secretion of pancreatic β-cell and insulin sensitivity index(ISI) were detected.and levels of adiponectin(APN)
interleukin-6(IL-6) and high-sensitivity c-reactive protein(hs-CRP) were also detected. Result: After treatment
compared with the time before treatment
waist and BMI in two groups decreased
which means no statistical significance from the differences between two groups
and there was a decreasing tendency of patients' weight.Levels of FBG
2 hPG
HbA1c and FINS in observation group were lower than those in control group(P<0.05 or P<0.01).HOMA-IR in observation group was lower than in control group(P<0.01) and HOMA-IS and ISI were higher than those in control group(P<0.01).Cases of turning normal of TC
TG
LDL-C and HDL-C in observation group were more than those in control group(P<0.01).Serous APN in observation group was higher than in control group(P<0.01)
and levels of IL-6 and hs-CRP in observation group were lower than those in control group(P<0.01). Conclusion: Shugan Jianpi decoction can regulate patients' glucose metabolism and lipid metabolism in treating early-stage diabetes
and prolong or reversion speed of early-stage diabetes turning into diabetes
its mechanism of action may be related to regulating APN
IL-6 and hs-CRP and reducing chronic inflammatory reaction.
0
浏览量
233
下载量
23
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621